Seeking Alpha

John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum)

MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ -- Endo, Inc. (NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his treatment with ...
Nasdaq

Endo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)

Campaign builds on the momentum of Endo's disease awareness efforts. Commercial features a real patient—who was an untreated patient in a prior Endo video series—and his wife, sharing their personal ...
MyChesCo on MSN

Endo, Inc. Shares Positive Data on XIAFLEX Treatment for Peyronie’s Disease

MALVERN, PA — Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of ...
Morningstar

Endo Announces Peyronie's Disease Presentation at the North Central Section of the American Urological Association

MALVERN, Pa., Oct. 15, 2025 /PRNewswire/ -- Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today that a presentation related to Peyronie's disease, or PD, and XIAFLEX® (collagenase ...